文献速递关节外科

鼻内聚维酮碘去定植耐甲氧西林金黄色葡萄球菌的成本效益

Cost Efficacy of Methicillin-Resistant Staphylococcus aureus Decolonization With Intranasal Povidone-Iodine.
PubMed 文献 · J Arthroplasty · 2018-01-31

该研究基于单机构超过4年的数据,评估连续全膝和全髋关节置换术患者的MRSA定植率及莫匹罗星去定植方案下的感染率,并建立成本分析模型比较使用聚维酮碘的成本。5584例中仅3.5%鼻内MRSA检测阳性,其中69%去定植成功;3864例有感染数据者中21例(0.54%)在90天内发生手术部位感染,且这些患者初始MRSA均为阴性。成本分析预测在本机构全关节置换术前使用全局鼻内聚维酮碘方案每位患者可节省74.72美元,结论中写为74.42美元。

要点

  • 单机构5584例中仅3.5%鼻内MRSA阳性,其中69%去定植成功。
  • 3864例有感染数据者中21例(0.54%)90天内发生手术部位感染,均初始MRSA阴性。
  • 成本分析预测全关节置换术前用鼻内聚维酮碘方案每位患者可节省74.72美元。

核心结论

  • 即使MRSA发生率低于通常报告水平,使用鼻内聚维酮碘可能每位患者节省74.42美元。

研究设计与样本

  • 利用超过4年的数据,评估连续全膝和全髋关节置换术的MRSA去定植发生率及未定植、成功去定植和未成功去定植患者的感染率,并据此建立成本分析模型。
  • 研究纳入单机构5584例有MRSA数据的病例和3864例有感染数据的病例。

主要发现

  • 5584例有MRSA数据的病例中,仅3.5%鼻内MRSA检测阳性。
  • 鼻内MRSA阳性患者中69%成功去定植。
  • 3864例有感染数据的病例中,21例在90天内发生手术部位感染(0.54%)。
  • 发生手术部位感染的患者初始鼻内MRSA均为阴性,因此未进行去定植方案。

关键数值与推荐

  • 成本分析预测在本机构全关节置换术前使用全局鼻内聚维酮碘方案,每位患者可节省74.72美元。
  • 结论中写为使用鼻内聚维酮碘可能每位患者节省74.42美元。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With increasing rates of virulent drug resistant organisms, MRSA (methicillin-resistant Staphylococcus aureus) decolonization has been demonstrated to decrease infection rates. Recent research has shown the antiseptic povidone-iodine to be equally effective and potentially cost saving compared to intranasal mupirocin. This study's purpose is to evaluate the incidence of MRSA colonization in a more rural community-based population, rates of infection on a mupirocin decolonization protocol, and develop a cost analysis model to compare costs of utilizing povidone-iodine. METHODS: Utilizing over 4 years of data, the incidence of MRSA decolonization of consecutive total knee and hip arthroplasties, as well as the rates of infection of patients uncolonized, colonized with successful decolonization, and unsuccessful decolonization were evaluated. Utilizing these data, cost data, and known infection rate utilizing povidone-iodine decolonization, a cost analysis model was developed. RESULTS: Of the 5584 cases with MRSA data at a single institution, only 3.5% tested positive for intranasal MRSA. Of those patients, 69% were successfully decolonized. Of the 3864 cases with infection data, 21 sustained a surgical site infection within 90 days (0.54%). Of these patients, all tested negative for intranasal MRSA initially and therefore did not undergo the decolonization protocol. The cost analysis predicts a potential savings of $74.72 per patient at our institution to use a global intranasal povidone-iodine protocol prior to total joint arthroplasty. CONCLUSION: Even with a lower incidence of MRSA than typically reported, utilization of intranasal povidone-iodine would potentially save $74.42 per patient.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Rieser GR, Moskal JT. Cost Efficacy of Methicillin-Resistant Staphylococcus aureus Decolonization With Intranasal Povidone-Iodine. J Arthroplasty. 2018. PMID: 29506927. doi:10.1016/j.arth.2018.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。